Turku

• A clinical study of V940 and pembrolizumab to treat lung cancer (V940-009) Recruiting
  2023-506327-29-00 5 2025-05-14 Non-Small Cell Lung Cancer
• A first-in-human study to learn about the safety of BAY 3547926 and how well it works in participants with advanced liver cancer Recruiting
  2024-516615-25-00 1 2025-05-14 hepatocellular carcinoma (HCC)
• Pooled human plasma vs. Crystalloid in the fluid management of children undergoing instrumented spinal fusion for scoliosis. A double-blind, … Recruiting
  2024-514857-31-00 4 2025-05-02 Neuromuscular scoliosis (NMS)
• A Phase 3 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with Relapsed or Refractory Multiple Myeloma and Exposed to Lenalido … Recruiting
  2024-515279-37-00 5 2025-04-17 Relapsed or Refractory and Lenalidomide exposed Multiple Myeloma
• A clinical proof-of-concept study to reduce smoldering inflammation in progressive MS Recruiting
  2024-517336-21-00 4 2025-03-31 Progressive multiple sclerosis
• Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C … Recruiting
  2024-515445-42-00 5 2025-03-24 Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
• C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant … Recruiting
  2024-511652-40-00 5 2025-02-05 METASTATIC CASTRATION RESISTANT PROSTATE CANCER
• RAXO trial - A population-based prospective study to evaluate clinical behaviour, resectability and survival in metastatic colorectal cancer … Recruiting
  2024-520288-15-00 6 2025-01-25 Metastatic or locally advanced inoperable colorectal cancer
• Prevention of thromboembolism during pancreatic cancer treatments - link to prognosis and relapse of the disease. Recruiting
  2024-512475-12-01 6 2024-11-27 We are investigating the efficacy and safety of enhanced thromboprophy
• Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting
  2024-513009-30-00 4 2024-11-21 Moderate to Severe Crohn’s Disease
• Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting
  2023-509994-22-00 5 2024-11-15 cutaneous malignant melanoma
• FINPROVE - The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Recruiting
  2024-517478-68-01 4 2024-11-06 Advanced Cancer
• Infections after hysterectomy - a placebo controlled study comparing the profylactic use of azithromycin and cefuroxime with single cefuroxi … Recruiting
  2024-517508-12-00 6 2024-10-24 Undergoing hysterectomy
• A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc … Recruiting
  2024-511319-91-00 5 2024-10-23 Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
• Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer Recruiting
  2024-510651-35-00 4 2024-10-14 Colon cancer
• Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer Recruiting
  2023-510208-39-00 4 2024-10-09 Pancreatic cancer
• The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Quality of Life Recruiting
  2024-513437-21-00 6 2024-10-02 Cancer
• Effect of xenon on brain injury, neurological outcome and survival in patients after aneurysmal subarachnoid hemorrhage Recruiting
  2022-500596-32-00 4 2024-10-01 Aneyrysmal subarachnoid hemorrhage needing ventilatory care in intensi
• VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Pat … Recruiting
  2024-510715-30-00 4 2024-09-26 VEXAS
• Clinical use of USPIO contrast media in the assessment of pelvic lymph node metastasis in rectal cancer. Recruiting
  2024-514831-34-00 5 2024-09-19 Rectal cancer
• A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting
  2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
• Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTR … Recruiting
  2023-504704-28-00 4 2024-09-01 Prostate cancer
• First-in-human study of 225Ac-PSMA-Trillium (BAY 3563254) in participants with advanced metastatic castration-resistant prostate cancer (mCR … Recruiting
  2023-507486-26-00 1 2024-08-20 Advanced metastatic castration-resistant prostate cancer with prostate
• Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting
  2023-508162-15-00 5 2024-07-12 Chronic HF and comorbid impairment of kidney function who had a recent

Showing 73–96 of 286 trials